Correlation Between Korea Environment and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Korea Environment and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korea Environment and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korea Environment Technology and AptaBio Therapeutics, you can compare the effects of market volatilities on Korea Environment and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korea Environment with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korea Environment and AptaBio Therapeutics.
Diversification Opportunities for Korea Environment and AptaBio Therapeutics
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Korea and AptaBio is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Korea Environment Technology and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Korea Environment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korea Environment Technology are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Korea Environment i.e., Korea Environment and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Korea Environment and AptaBio Therapeutics
Assuming the 90 days trading horizon Korea Environment Technology is expected to generate 0.66 times more return on investment than AptaBio Therapeutics. However, Korea Environment Technology is 1.51 times less risky than AptaBio Therapeutics. It trades about 0.19 of its potential returns per unit of risk. AptaBio Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 695,382 in Korea Environment Technology on October 21, 2024 and sell it today you would earn a total of 197,618 from holding Korea Environment Technology or generate 28.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Korea Environment Technology vs. AptaBio Therapeutics
Performance |
Timeline |
Korea Environment |
AptaBio Therapeutics |
Korea Environment and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Korea Environment and AptaBio Therapeutics
The main advantage of trading using opposite Korea Environment and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korea Environment position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.Korea Environment vs. Daou Data Corp | Korea Environment vs. Busan Industrial Co | Korea Environment vs. Busan Ind | Korea Environment vs. Mirae Asset Daewoo |
AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |